- Home
- MOB vs PULM Comparison
MOB vs PULM Comparison
Compare MOB & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOB
- PULM
- Stock Information
- Founded
- MOB 2008
- PULM 2003
- Country
- MOB Israel
- PULM United States
- Employees
- MOB N/A
- PULM N/A
- Industry
- MOB Real Estate Investment Trusts
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- MOB Real Estate
- PULM Health Care
- Exchange
- MOB Nasdaq
- PULM Nasdaq
- Market Cap
- MOB 18.0M
- PULM 21.0M
- IPO Year
- MOB 2022
- PULM N/A
- Fundamental
- Price
- MOB $2.50
- PULM $7.10
- Analyst Decision
- MOB
- PULM
- Analyst Count
- MOB 0
- PULM 0
- Target Price
- MOB N/A
- PULM N/A
- AVG Volume (30 Days)
- MOB 440.5K
- PULM 37.6K
- Earning Date
- MOB 03-25-2025
- PULM 03-27-2025
- Dividend Yield
- MOB N/A
- PULM N/A
- EPS Growth
- MOB N/A
- PULM N/A
- EPS
- MOB N/A
- PULM N/A
- Revenue
- MOB $3,464,353.00
- PULM $10,005,000.00
- Revenue This Year
- MOB N/A
- PULM N/A
- Revenue Next Year
- MOB N/A
- PULM $1.00
- P/E Ratio
- MOB N/A
- PULM N/A
- Revenue Growth
- MOB 169.70
- PULM 47.05
- 52 Week Low
- MOB $0.71
- PULM $1.55
- 52 Week High
- MOB $5.00
- PULM $8.44
- Technical
- Relative Strength Index (RSI)
- MOB 40.80
- PULM 62.30
- Support Level
- MOB $2.67
- PULM $6.84
- Resistance Level
- MOB $3.13
- PULM $8.14
- Average True Range (ATR)
- MOB 0.34
- PULM 0.39
- MACD
- MOB -0.10
- PULM 0.11
- Stochastic Oscillator
- MOB 14.06
- PULM 71.43
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.